Abstract
Neutralizing Enterovirus D68 Antibodies in Children after 2014 Outbreak, Kansas City, Missouri, USA.
Highlights
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases
Participants will earn Maintenance of Certification (MOC) points equivalent to the amount of CME credits claimed for the activity
Describe neutralizing Enterovirus D68 (EV-D68) antibodies to the 2014 B1, 2014 B2, and 2014 D clade virus in pediatric sera salvaged during 2017 in patients aged 6 months to 18 years, including persons born after the 2014 outbreak, according to a serologic study in Kansas City, Missouri
Summary
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Describe neutralizing EV-D68 antibodies to the 2014 B1, 2014 B2, and 2014 D clade virus in pediatric sera salvaged during 2017 in patients aged 6 months to 18 years, including persons born after the 2014 outbreak, according to a serologic study in Kansas City, Missouri
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
